Filing Details

Accession Number:
0001363763-15-000018
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-08-31 16:21:52
Reporting Period:
2015-08-28
Filing Date:
2015-08-31
Accepted Time:
2015-08-31 16:21:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
849636 Cortex Pharmaceuticals Inc CORX Pharmaceutical Preparations (2834) 330303583
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1236365 J S James Manuso C/O Cortex Pharmaceuticals, Inc.
126 Valley Road, Suite C
Glen Rock NJ 07452
President And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-08-28 11,887,779 $0.00 11,887,779 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants (right to buy) Acquisiton 2015-08-28 23,775,558 $0.00 23,775,558 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
23,775,558 2015-08-28 2020-09-30 No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Common Stock Options (to purchase shares of Common Stock) $0.02 2025-08-18 5,081,300 5,081,300 Direct
Common Stock Common Stock Options (to purchase shares of Common Stock) $0.02 2025-08-18 80,000,000 80,000,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2025-08-18 5,081,300 5,081,300 Direct
2025-08-18 80,000,000 80,000,000 Direct
Footnotes
  1. The reported securities are included within 11,887,779 units purchased by the reporting person for $0.02103 per unit. Each unit consists of one share of Common Stock and one warrant to purchase two additional shares of Common Stock with an exercise price of $0.02103 for each share of Common Stock to be issued upon exercise of the warrant.
  2. These Common Stock Options vest in three installments: 50 percent on August 18, 2015 (the grant date), 25 percent on February 18, 2016, and 25 percent on August 18, 2016.